Clinical trial

Investigational Device Exemption (IDE) Study for the Approval of Closed Loop Stimulation (CLS) and Cardiac Resyncronization Pacing Therapies (CRT) for the Treatment of Atrial Fibrillation (AF) With Ablate and Pace

NCT00356057

StatusTERMINATED

Study typeINTERVENTIONAL

Start date2004-12-01

PhaseNA

Study timeline

Study start (unknown)2004-12-01Date precision: month

Registry last updated2018-02-27

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Atrial Fibrillationunresolved

Congestive Heart Failureunresolved

Interventions

Protos DR/CLS and Stratos LV CRT pacemakersDEVICE

Sponsors & collaborators

Biotronik, Inc.lead sponsor

Mapped research locations

New YorkNew York, United States1 BostonMassachusetts, United States1 BirminghamAlabama, United States1 ColumbusOhio, United States1 Ann ArborMichigan, United States1 SpartanburgSouth Carolina, United States1 CantonOhio, United States1 AmarilloTexas, United States1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT00356057 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.